Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Negative Breast Cancer Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05541367
What this trial is testing

Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer

Who this might be right for
Breast CancerTNBC - Triple-Negative Breast CancerEstrogen-receptor-negative Breast Cancer
Tongji Hospital 80
Not applicableLooking for participantsNCT07290153
What this trial is testing

Psychological State, Immunotherapy Response, and Multi-Omics Signatures in TNBC

Who this might be right for
Breast Cancer Female NOSGeneral Anxiety DisorderDepressive Disorder
Fudan University 120
Not applicableUnknownNCT04045522
What this trial is testing

Study on Bisphosphonates Targeting Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
Shengjing Hospital 120
Not applicableActive Not RecruitingNCT04314401
What this trial is testing

National Cancer Institute "Cancer Moonshot Biobank"

Who this might be right for
Acute Myeloid LeukemiaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+26 more
National Cancer Institute (NCI) 1,600
Early research (Phase 1)WithdrawnNCT02427581
What this trial is testing

Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

Who this might be right for
Triple Negative Breast CancerTriple Negative Breast NeoplasmsTriple-Negative Breast Cancer
Washington University School of Medicine
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07101614
What this trial is testing

Study of JS004 and Toripalimab Combined With Chemotherapy vs Toripalimab Combined With Chemotherapy vs Chemotherapy Alone as Neoadjuvant Therapy for Stage II-III Triple-negative Breast Cancer (TNBC).

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Shengjing Hospital 125
Not applicableNot Yet RecruitingNCT06684054
What this trial is testing

Studying the Senescent T Cell Features and Its Relationship with the Chemotherapy Efficacy in Young TNBC

Who this might be right for
T-Cell DysfunctionChemotherapy EffectAdverse Events
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 30
Early research (Phase 1)UnknownNCT04107142
What this trial is testing

Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour

Who this might be right for
Colorectal CancerTriple Negative Breast CancerSarcoma+3 more
CytoMed Therapeutics Pte Ltd 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT02644369
What this trial is testing

Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors

Who this might be right for
Squamous Cell Cancer of Head and NeckTriple Negative Breast CancerEpithelial Ovarian Cancer+2 more
University Health Network, Toronto 100
Testing effectiveness (Phase 2)Looking for participantsNCT06099769
What this trial is testing

Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Memorial Sloan Kettering Cancer Center 201
Not applicableStudy completedNCT03586297
What this trial is testing

Gut and Intratumoral Microbiome Effect on the Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Hackensack Meridian Health 49
Early research (Phase 1)Ended earlyNCT03343613
What this trial is testing

LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerRenal Cell Carcinoma+1 more
Eli Lilly and Company 60
Testing effectiveness (Phase 2)Study completedNCT00479674
What this trial is testing

Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Duke University 41
Not applicableUnknownNCT03332368
What this trial is testing

Clinical Study on Triple Negative Breast Cancer With Chinese Medicine

Who this might be right for
Progression-Free-SurvivalRecurrenceOverall Survival
Sheng Liu 620
Early research (Phase 1)Study completedNCT02950259
What this trial is testing

Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)

Who this might be right for
Breast NeoplasmBreast Neoplasm, MaleTriple Negative Breast Cancer
Providence Health & Services 16
Not applicableLooking for participantsNCT07773818
What this trial is testing

Establishment of a Multi-omics Prediction Model for Early Triple-negative Breast Cancer Based on UPGRADE-TNBC Study

Who this might be right for
Triple -Negative Breast CancertripleMeta-LearningPredictive Models+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 32
Large-scale testing (Phase 3)Study completedNCT02819518
What this trial is testing

Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)

Who this might be right for
Triple Negative Breast Cancer (TNBC)
Merck Sharp & Dohme LLC 882
Testing effectiveness (Phase 2)UnknownNCT03444025
What this trial is testing

Neoadjuvant Goserelin for Triple Negative Breast Cancer

Who this might be right for
Breast Cancer Triple Negative
Kasr El Aini Hospital 180
Early research (Phase 1)Not Yet RecruitingNCT07423117
What this trial is testing

ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy

Who this might be right for
Metastatic Castration-resistant Prostate CancerNon-small Cell Lung CancerTriple Negative Breast Cancer+1 more
IntoCell, Inc 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT05057013
What this trial is testing

A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours

Who this might be right for
Bladder CancerTriple Negative Breast CancerCastration-resistant Prostate Cancer+11 more
Cancer Research UK 81
Next Page